Teva Pharmaceutical Industries Ltd. (TEVA)
42.57
-1.93
(-4.34%)
USD |
NYSE |
Nov 16, 16:00
42.36
-0.21
(-0.49%)
Pre-Market: 06:21
Teva Pharmaceutical Industries Price : 42.57 for Nov. 16, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 16, 2026 | 44.30 | 44.57 | 42.52 | 42.57 | 7.461M |
| Nov 13, 2026 | 43.91 | 44.56 | 43.43 | 44.50 | 7.563M |
| Nov 12, 2026 | 43.52 | 44.31 | 43.18 | 43.65 | 9.251M |
| Nov 11, 2026 | 42.71 | 43.24 | 42.38 | 43.24 | 9.563M |
| Nov 10, 2026 | 42.46 | 42.69 | 41.64 | 42.40 | 6.224M |
| Nov 09, 2026 | 43.01 | 43.18 | 42.66 | 42.97 | 4.578M |
| Nov 06, 2026 | 41.47 | 42.63 | 41.41 | 42.61 | 6.197M |
| Nov 05, 2026 | 41.49 | 42.38 | 40.92 | 41.78 | 13.71M |
| Nov 04, 2026 | 41.89 | 42.59 | 41.29 | 41.85 | 10.04M |
| Nov 03, 2026 | 41.90 | 43.34 | 41.54 | 41.91 | 11.67M |
| Nov 02, 2026 | 41.12 | 42.00 | 40.63 | 40.70 | 10.59M |
| Oct 30, 2026 | 41.17 | 42.59 | 41.17 | 42.09 | 7.358M |
| Oct 29, 2026 | 40.14 | 41.67 | 40.01 | 41.47 | 5.232M |
| Oct 28, 2026 | 39.74 | 40.50 | 39.46 | 39.97 | 4.647M |
| Oct 27, 2026 | 39.71 | 40.86 | 39.71 | 40.39 | 5.979M |
| Oct 26, 2026 | 39.22 | 40.12 | 39.15 | 39.95 | 6.032M |
| Oct 23, 2026 | 39.75 | 39.84 | 39.10 | 39.41 | 5.599M |
| Oct 22, 2026 | 40.20 | 40.44 | 39.58 | 40.21 | 4.069M |
| Oct 21, 2026 | 40.18 | 41.09 | 39.50 | 40.62 | 4.597M |
| Oct 20, 2026 | 41.48 | 41.59 | 40.80 | 40.85 | 4.224M |
| Oct 19, 2026 | 41.42 | 41.88 | 41.25 | 41.31 | 3.828M |
| Oct 16, 2026 | 41.26 | 41.70 | 40.96 | 41.50 | 5.990M |
| Oct 15, 2026 | 41.30 | 41.85 | 41.03 | 41.11 | 9.410M |
| Oct 14, 2026 | 41.11 | 41.87 | 40.71 | 40.72 | 10.27M |
| Oct 13, 2026 | 41.23 | 41.65 | 40.96 | 41.25 | 6.819M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Merck & Co., Inc. | 144.46 |
| Bristol Myers Squibb Co. | 62.93 |
| Eli Lilly & Co. | 1431.67 |
| Pfizer Inc. | 28.86 |
| Sanofi | 48.39 |
Price Related Metrics
| PE Ratio | 102.26 |
| PS Ratio | 2.892 |
| Price to Book Value | 6.226 |
| Price to Free Cash Flow | 40.80 |
| Earnings Yield | 0.98% |
| Market Cap | 49.68B |
| Operating PE Ratio | 15.11 |
| Normalized PE Ratio | 27.06 |